- £875.56m
- £1.24bn
- €3.07bn
Brief: Uniphar Says Well Positioned To Deliver FY Organic Gross Profit Growth Across All Divisions
Brief: Uniphar FY adjusted pretax profit EUR 53.321 million
2023 Preliminary Results
Holding(s) in Company
Brief: Uniphar Says Co Sees 2024 Organic Gross Profit Growth For Uniphar Pharma Up Double Digit
Directorate Change
Full Year Trading Update and Notice of Results
Holding(s) in Company
Director/PDMR Shareholding
Director/PDMR Shareholding
Director/PDMR Shareholding
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Brief: Uniphar Remains Well Positioned To Achieve Continued Gross Profit Growth In Each Division
2023 Interim Results
Holding(s) in Company
Holding(s) in Company
Brief: Uniphar Remains Confident In Delivering On Current Year Ebitda Expectations At Group Level